Literature DB >> 9278247

Potent and selective gene inhibition using antisense oligodeoxynucleotides.

W M Flanagan1, R W Wagner.   

Abstract

The development of antisense technology as a generally useful tool relies on the use of potent agents and the utilization of many controls in experiments. Here we describe our experience using oligodeoxynucleotides (ODNs) containing C-5 propynyl pyrimidine and phosphorothioate modifications as broadly applicable gene inhibition agents in cell culture. Methods include selection of antisense sequences, synthesis and purification of ODNs, choice of controls, delivery methods (microinjection, cationic lipid transfection, and electroporation), and analysis of gene inhibition.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9278247

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  27 in total

1.  Intracellular distribution of microinjected antisense oligonucleotides.

Authors:  J P Leonetti; N Mechti; G Degols; C Gagnor; B Lebleu
Journal:  Proc Natl Acad Sci U S A       Date:  1991-04-01       Impact factor: 11.205

2.  Site and mechanism of antisense inhibition by C-5 propyne oligonucleotides.

Authors:  C Moulds; J G Lewis; B C Froehler; D Grant; T Huang; J F Milligan; M D Matteucci; R W Wagner
Journal:  Biochemistry       Date:  1995-04-18       Impact factor: 3.162

3.  A serum-resistant cytofectin for cellular delivery of antisense oligodeoxynucleotides and plasmid DNA.

Authors:  J G Lewis; K Y Lin; A Kothavale; W M Flanagan; M D Matteucci; R B DePrince; R A Mook; R W Hendren; R W Wagner
Journal:  Proc Natl Acad Sci U S A       Date:  1996-04-16       Impact factor: 11.205

4.  Antisense oligonucleotides inhibit intercellular adhesion molecule 1 expression by two distinct mechanisms.

Authors:  M Y Chiang; H Chan; M A Zounes; S M Freier; W F Lima; C F Bennett
Journal:  J Biol Chem       Date:  1991-09-25       Impact factor: 5.157

5.  Problems in interpretation of data derived from in vitro and in vivo use of antisense oligodeoxynucleotides.

Authors:  C A Stein; A M Krieg
Journal:  Antisense Res Dev       Date:  1994

6.  Acute- and chronic-phase chronic myelogenous leukemia colony-forming units are highly sensitive to the growth inhibitory effects of c-myb antisense oligodeoxynucleotides.

Authors:  M Z Ratajczak; N Hijiya; L Catani; K DeRiel; S M Luger; P McGlave; A M Gewirtz
Journal:  Blood       Date:  1992-04-15       Impact factor: 22.113

7.  Single intraluminal delivery of antisense cdc2 kinase and proliferating-cell nuclear antigen oligonucleotides results in chronic inhibition of neointimal hyperplasia.

Authors:  R Morishita; G H Gibbons; K E Ellison; M Nakajima; L Zhang; Y Kaneda; T Ogihara; V J Dzau
Journal:  Proc Natl Acad Sci U S A       Date:  1993-09-15       Impact factor: 11.205

8.  Cationic lipids enhance cellular uptake and activity of phosphorothioate antisense oligonucleotides.

Authors:  C F Bennett; M Y Chiang; H Chan; J E Shoemaker; C K Mirabelli
Journal:  Mol Pharmacol       Date:  1992-06       Impact factor: 4.436

9.  High levels of HIV-1 in plasma during all stages of infection determined by competitive PCR.

Authors:  M Piatak; M S Saag; L C Yang; S J Clark; J C Kappes; K C Luk; B H Hahn; G M Shaw; J D Lifson
Journal:  Science       Date:  1993-03-19       Impact factor: 47.728

10.  Modulation of human prorenin gene expression by antisense oligonucleotides in transfected CHO cells.

Authors:  F Cumin; F Asselbergs; M Lartigot; E Felder
Journal:  Eur J Biochem       Date:  1993-03-01
View more
  6 in total

1.  Antisense inhibition of gene expression in cells by oligonucleotides incorporating locked nucleic acids: effect of mRNA target sequence and chimera design.

Authors:  Dwaine A Braasch; Yinghui Liu; David R Corey
Journal:  Nucleic Acids Res       Date:  2002-12-01       Impact factor: 16.971

2.  Selection of antisense oligodeoxynucleotides against glutathione S-transferase Mu.

Authors:  Peter A C 't Hoen; Ruud Out; Jan N M Commandeur; Nico P E Vermeulen; F H D van Batenburg; Muthiah Manoharan; Theo J C van Berkel; Erik A L Biessen; Martin K Bijsterbosch
Journal:  RNA       Date:  2002-12       Impact factor: 4.942

3.  Identification of genes involved in liver cancer cell growth using an antisense library of phage genomic DNA.

Authors:  Yun Han Lee; Young Ho Kim; Jong Gu Park
Journal:  Cancer Res Treat       Date:  2004-08-31       Impact factor: 4.679

4.  A cytosine analog that confers enhanced potency to antisense oligonucleotides.

Authors:  W M Flanagan; J J Wolf; P Olson; D Grant; K Y Lin; R W Wagner; M D Matteucci
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-30       Impact factor: 11.205

Review 5.  Morpholino antisense oligonucleotides: tools for investigating vertebrate development.

Authors:  D R Corey; J M Abrams
Journal:  Genome Biol       Date:  2001-04-26       Impact factor: 13.583

6.  Synthesis and properties of DNA oligomers containing stereopure phosphorothioate linkages and C-5 modified deoxyuridine derivatives.

Authors:  Rintaro Iwata Hara; Reijiro Yoshino; Yohei Nukaga; Yusuke Maeda; Kazuki Sato; Takeshi Wada
Journal:  RSC Adv       Date:  2020-09-15       Impact factor: 4.036

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.